Cargando…
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine
Autores principales: | Niebel, Dennis, Ralser‐Isselstein, Veronika, Jaschke, Kristel, Braegelmann, Christine, Bieber, Thomas, Wenzel, Joerg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209903/ https://www.ncbi.nlm.nih.gov/pubmed/34075664 http://dx.doi.org/10.1111/dth.15017 |
Ejemplares similares
-
Annular plaques mimicking Rowell’s syndrome in the course of coronavirus disease 2019 mRNA vaccines: An overlooked phenomenon?
por: Niebel, Dennis, et al.
Publicado: (2021) -
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective
por: Niebel, Dennis, et al.
Publicado: (2021) -
Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus
por: Fetter, Tanja, et al.
Publicado: (2022) -
Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions
por: Fetter, Tanja, et al.
Publicado: (2020) -
Tozinameran: Exacerbation of subacute cutaneous lupus erythematosus: case report
Publicado: (2021)